Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults

NCT01892189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Ketamine-Induced Brain Activity Changes
Psychotic-like Symptoms

Interventions

DRUG: Ketamine
DRUG: TAK-063
DRUG: TAK-063 Placebo

Sponsor

Takeda